These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19762089)

  • 21. [The original nootropic and neuroprotective drug noopept potentiates the anticonvulsant activity of valproate in mice].
    Kravchenko EV; Ponteleeva IV; Trofimov SS; Lapa VI; Ostrovskaia RU; Voronina TA
    Eksp Klin Farmakol; 2009; 72(6):15-7. PubMed ID: 20095393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is sodium valproate, an HDAC inhibitor, associated with reduced risk of stroke and myocardial infarction? A nested case-control study.
    Dregan A; Charlton J; Wolfe CD; Gulliford MC; Markus HS
    Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):759-67. PubMed ID: 24890032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histone deacetylases as targets for the treatment of human neurodegenerative diseases.
    D'Mello SR
    Drug News Perspect; 2009 Nov; 22(9):513-24. PubMed ID: 20072728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic effects of GSK-3β and HDAC inhibitors in intracerebroventricular streptozotocin-induced cognitive deficits in rats.
    Sharma S; Taliyan R
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Mar; 388(3):337-49. PubMed ID: 25547373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opposing Effects of Valproic Acid Treatment Mediated by Histone Deacetylase Inhibitor Activity in Four Transgenic
    Vent-Schmidt RYJ; Wen RH; Zong Z; Chiu CN; Tam BM; May CG; Moritz OL
    J Neurosci; 2017 Jan; 37(4):1039-1054. PubMed ID: 28490005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histone deacetylase 2: A potential therapeutic target for cancer and neurodegenerative disorders.
    Gediya P; Parikh PK; Vyas VK; Ghate MD
    Eur J Med Chem; 2021 Apr; 216():113332. PubMed ID: 33714914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined diazepam and HDAC inhibitor treatment protects against seizures and neuronal damage caused by soman exposure.
    Rossetti F; de Araujo Furtado M; Pak T; Bailey K; Shields M; Chanda S; Addis M; Robertson BD; Moffett M; Lumley LA; Yourick DL
    Neurotoxicology; 2012 Jun; 33(3):500-11. PubMed ID: 22387230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition.
    Leng Y; Liang MH; Ren M; Marinova Z; Leeds P; Chuang DM
    J Neurosci; 2008 Mar; 28(10):2576-88. PubMed ID: 18322101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition.
    Jeong MR; Hashimoto R; Senatorov VV; Fujimaki K; Ren M; Lee MS; Chuang DM
    FEBS Lett; 2003 May; 542(1-3):74-8. PubMed ID: 12729901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotective effects of valproic acid on brain ischemia are related to its HDAC and GSK3 inhibitions.
    Silva MR; Correia AO; Dos Santos GCA; Parente LLT; de Siqueira KP; Lima DGS; Moura JA; da Silva Ribeiro AE; Costa RO; Lucetti DL; Lucetti ECP; Neves KRT; de Barros Viana GS
    Pharmacol Biochem Behav; 2018 Apr; 167():17-28. PubMed ID: 29452136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Previous prolonged clonic seizures diminish antiepileptic activity of valproate against pentetrazol-evoked convulsions.
    Haberek G; Tomczyk T; Urbańska EM
    Pol J Pharmacol; 2001; 53(1):81-2. PubMed ID: 11785918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Valproate and neuroprotective effects for bipolar disorder.
    Atmaca M
    Int Rev Psychiatry; 2009; 21(4):410-3. PubMed ID: 20374154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sodium valproate, a histone deacetylase inhibitor, but not captopril, prevents right ventricular hypertrophy in rats.
    Cho YK; Eom GH; Kee HJ; Kim HS; Choi WY; Nam KI; Ma JS; Kook H
    Circ J; 2010 Apr; 74(4):760-70. PubMed ID: 20208383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer risk in long-term users of valproate: a population-based case-control study.
    Hallas J; Friis S; Bjerrum L; Støvring H; Narverud SF; Heyerdahl T; Grønbaek K; Andersen M
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1714-9. PubMed ID: 19505904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The therapeutic and neuroprotective effects of an antiepileptic drug valproic acid in glioma patients.
    Li C; Chen H; Tan Q; Xie C; Zhan W; Sharma A; Sharma HS; Zhang Z
    Prog Brain Res; 2020; 258():369-379. PubMed ID: 33223038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valproate attenuates the proteinuria, podocyte and renal injury by facilitating autophagy and inactivation of NF-κB/iNOS signaling in diabetic rat.
    Khan S; Jena G; Tikoo K; Kumar V
    Biochimie; 2015 Mar; 110():1-16. PubMed ID: 25572918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valproate in the treatment of epilepsy in people with intellectual disability.
    Friis ML
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():32-5. PubMed ID: 10030429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of histone deacetylase inhibitor sodium valproate on the physical and behavioral development of 129SV mice].
    Burenkova OV; Aleksandrova EA; Zarayskaya IY
    Patol Fiziol Eksp Ter; 2015; 59(2):40-5. PubMed ID: 26571806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sodium Valproate Ameliorates Neuronal Apoptosis in a Kainic Acid Model of Epilepsy via Enhancing PKC-Dependent GABA
    Li Q; Li QQ; Jia JN; Cao S; Wang ZB; Wang X; Luo C; Zhou HH; Liu ZQ; Mao XY
    Neurochem Res; 2018 Dec; 43(12):2343-2352. PubMed ID: 30311181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydralazine-valproate: a repositioned drug combination for the epigenetic therapy of cancer.
    Dueñas-Gonzalez A; Coronel J; Cetina L; González-Fierro A; Chavez-Blanco A; Taja-Chayeb L
    Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1433-44. PubMed ID: 25154405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.